Damora Therapeutics, Inc. SEC filings DMRA
Damora Therapeutics, Inc. has 353 filings in SEC EDGAR's recent list, going back to Jan 16, 2020. Its latest annual report, Form ARS, was filed on May 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 20, 2026 (material agreement, change to shareholder rights, bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 25, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 12, 2026 |
| 3 | Initial insider ownership | Aug 13, 2026 | Aug 12, 2026 |
| EFFECT | Filing | Aug 12, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| POSASR | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| POS AM | Filing | Aug 10, 2026 | — |
| 8-A12B/A | Filing | Aug 10, 2026 | — |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 144 | Notice of proposed sale | Aug 6, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2026 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 20, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 3, 2026 |
| 144 | Notice of proposed sale | Jun 22, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Apr 28, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | May 8, 2026 | May 1, 2026 |
| 8-K |
Current report
Officer or director change
|
May 4, 2026 | Apr 28, 2026 |
| ARS | Annual report to shareholders | May 1, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 23, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 23, 2026 | — |
| 8-K |
Current report
Auditor change
|
Apr 20, 2026 | Apr 17, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 3 | Initial insider ownership | Mar 25, 2026 | Mar 23, 2026 |
| 3 | Initial insider ownership | Mar 25, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 23, 2026 | Mar 20, 2026 |
| S-8 | Employee stock plan registration | Mar 20, 2026 | — |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 10, 2026 | Mar 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 6, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 12, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 9, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 11, 2026 | — |
| 8-K |
Current report
Material agreement
|
Feb 11, 2026 | Feb 10, 2026 |
| 424B5 | Prospectus supplement | Feb 11, 2026 | — |
| 424B5 | Prospectus supplement | Feb 10, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 10, 2026 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 5, 2026 |
| 3 | Initial insider ownership | Jan 26, 2026 | Jan 5, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 12, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 3 | Initial insider ownership | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Jan 6, 2026 | Dec 31, 2025 |
| S-8 | Employee stock plan registration | Jan 2, 2026 | — |
| DEF 14A | Proxy statement | Dec 31, 2025 | Feb 9, 2026 |
| 424B3 | Prospectus | Dec 31, 2025 | — |
| EFFECT | Filing | Dec 23, 2025 | — |
| CORRESP | Letter to the SEC | Dec 22, 2025 | — |
| PRE 14A | Preliminary proxy statement | Dec 16, 2025 | Dec 16, 2025 |
| S-3 | Shelf registration | Dec 16, 2025 | — |
| 8-K/A |
Amended current report
Bylaw or fiscal year change
|
Dec 9, 2025 | Nov 10, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 5, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 5, 2025 | — |
| D | Filing | Nov 21, 2025 | — |
| 3 | Initial insider ownership | Nov 17, 2025 | Nov 10, 2025 |
| 3 | Initial insider ownership | Nov 17, 2025 | Nov 10, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Nov 17, 2025 | — |
| 3 | Initial insider ownership | Nov 17, 2025 | Nov 10, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 13, 2025 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 9, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 25, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 8, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 8, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 8, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 18, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2025 | Jun 18, 2025 |
| S-8 | Employee stock plan registration | Mar 19, 2025 | — |
| 10-K | Annual report | Mar 19, 2025 | Dec 31, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 16, 2025 | — |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 7, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 1, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 11, 2024 |
| 3 | Initial insider ownership | Oct 15, 2024 | Oct 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 3 | Initial insider ownership | Oct 11, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 7, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Other events
|
Sep 18, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Other events
|
Sep 11, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 5, 2024 | Aug 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 29, 2024 | — |
| 3 | Initial insider ownership | Aug 16, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 24, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 10-Q | Quarterly report | Apr 29, 2024 | Mar 31, 2024 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 20, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Mar 26, 2024 | Mar 22, 2024 |
| S-8 | Employee stock plan registration | Mar 8, 2024 | — |
| 10-K | Annual report | Mar 8, 2024 | Dec 31, 2023 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Other events
|
Dec 21, 2023 | Dec 21, 2023 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Oct 23, 2023 | Oct 23, 2023 |
| SC 13G | Ownership over 5% (passive) | Oct 3, 2023 | — |
| 144 | Notice of proposed sale | Oct 2, 2023 | — |
| 144 | Notice of proposed sale | Oct 2, 2023 | — |
| 144 | Notice of proposed sale | Oct 2, 2023 | — |
| 144 | Notice of proposed sale | Oct 2, 2023 | — |
| 8-K |
Current report
Listing notice
|
Oct 2, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Sep 26, 2023 | Sep 20, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 18, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 5, 2023 | — |
| 144 | Notice of proposed sale | Aug 30, 2023 | — |
| 144 | Notice of proposed sale | Aug 30, 2023 | — |
| 144 | Notice of proposed sale | Aug 30, 2023 | — |
| 144 | Notice of proposed sale | Aug 30, 2023 | — |
| 144/A | Filing | Aug 21, 2023 | — |
| 144 | Notice of proposed sale | Aug 21, 2023 | — |
| 144 | Notice of proposed sale | Aug 21, 2023 | — |
| 144 | Notice of proposed sale | Aug 21, 2023 | — |
| 144 | Notice of proposed sale | Aug 21, 2023 | — |
| 4 | Insider transaction | Aug 17, 2023 | Aug 15, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 17, 2023 | — |
| 144 | Notice of proposed sale | Aug 15, 2023 | — |
| 144 | Notice of proposed sale | Aug 15, 2023 | — |
| 144 | Notice of proposed sale | Aug 15, 2023 | — |
| 144 | Notice of proposed sale | Aug 15, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 15, 2023 | Aug 15, 2023 |
| 4 | Insider transaction | Aug 2, 2023 | Jul 31, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 2, 2023 | — |
| 144 | Notice of proposed sale | Jul 31, 2023 | — |
| 144 | Notice of proposed sale | Jul 31, 2023 | — |
| 144 | Notice of proposed sale | Jul 31, 2023 | — |
| 144 | Notice of proposed sale | Jul 31, 2023 | — |
| 10-Q | Quarterly report | Jul 31, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 27, 2023 | Jul 25, 2023 |
| 144 | Notice of proposed sale | Jul 25, 2023 | — |
| 144 | Notice of proposed sale | Jul 25, 2023 | — |
| 144 | Notice of proposed sale | Jul 25, 2023 | — |
| 144 | Notice of proposed sale | Jul 25, 2023 | — |
| 4 | Insider transaction | Jul 17, 2023 | Jul 13, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 17, 2023 | — |
| 144 | Notice of proposed sale | Jul 13, 2023 | — |
| 144 | Notice of proposed sale | Jul 13, 2023 | — |
| 144 | Notice of proposed sale | Jul 13, 2023 | — |
| 144 | Notice of proposed sale | Jul 13, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 14, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 14, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 14, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 14, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 14, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DMRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1800315
- Former names
- Galecto, Inc. (until Mar 10, 2026); Galecto Inc. (until Oct 28, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.